BIOPEP-UWM: Report
| ID | 57 |
| Name | Antiviral peptide |
| sequence |
| Function: | |||
| Predicted ligand of SARS-CoV-2 parent protease (EC 3.4.22.69) (MEROPS ID: C30.007) (PDB ID: 6LU7) | |||
| Number of residues | 3 |
Activity code | avi |
| Activity : | antiviral |
|||
| Chemical mass | 407.5025 | Monoisotopic mass | 407.2412 | |
| EC50 : | 0.00 µM |
|||
| Bibliographic data: | |
| Authors | |
| Behzadipour Y., Gholampour M., Pirhadi S., Seradj H., Khoshneviszadeh M., Hemmati S. | |
| Title | |
| Viral 3CLpro as a target for antiviral intervention using milk‑derived bioactive peptides. Int. J. Pept. Res. Therapeut., 27, 2703–2716, 2021 | |
| Year | Source |
| 2021 | Journal |
| Additional information: |
| BIOPEP-UWM Virtual database SMILES: N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O InChI=1S/C21H33N3O5/c1-12(2)9-16(22)19(26)23-17(10-13(3)4)20(27)24-18(21(28)29)11-14-5-7-15(25)8-6-14/h5-8,12-13,16-18,25H,9-11,22H2,1-4H3,(H,23,26)(H,24,27)(H,28,29)/t16-,17-,18-/m0/s1 InChIKey=UCNNZELZXFXXJQ-BZSNNMDCSA-N Bioactivity predicted using molecular docking Immunomodulatory pepeptide according to the BIOPEP-UWM database of bioactive peptides (ID 3065), the EROP-Moscow database; the MBPDB database Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001) according to the BIOPEP-UWM database of bioactive peptides (ID 10167); the MBPDB database Antioxidative peptide according to the BIOPEP-UWM database of bioactive peptides (ID 101168); the MBPDB database |
| Database reference: |
| ACToR: ID 20368-24-5 BIOPEP-UWM database of bioactive peptides: ID 3065; 10167; 10168 BRENDA: Ligand Leu-Leu-Tyr ChEBI: ID 6415 ChemIDplus: ID 20368-24-5 ChemSpider: ID 79864 CTD: ID 20368-24-5 EROP-Moscow: ID E01884 FeptideDB: ID 3065 J-GLOBAL: ID 200907096522740788 KEGG: ID C11331 MBPDB: Peptide LLY Nikkaji: ID J492.339A PubChem: CID 88513 |